Stroke risk in hypertrophic cardiomyopathy patients with atrial fibrillation: a nationwide database study

Current treatment guidelines recommend anticoagulation for hypertrophic cardiomyopathy (HCM) with atrial fibrillation (AF) regardless of the CHA(2)DS(2)-VASc score. As aging and stroke risk factors (hypertension, diabetes mellitus) are confounders of ischemic stroke, young patients with a low stroke...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Jung-Chi, Huang, Ya-Ting, Lin, Lian-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762520/
https://www.ncbi.nlm.nih.gov/pubmed/33226371
http://dx.doi.org/10.18632/aging.104133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762520/
https://www.ncbi.nlm.nih.gov/pubmed/33226371
http://dx.doi.org/10.18632/aging.104133

Ejemplares similares